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Abstract 
Clinical decision-making is becoming increasingly complex because of greater patient access to 
information, more clinical options and the emphasis on patient-centred care with informed decision-
making. Risk communication should form part of evidence-based clinical practice, and it is important 
to think about what happens when clinicians adopt different consultation approaches. In thisarticle, 
the ethical consequences of risk communication are analysed by looking at how the paternalistic and 
shared decision-making models of consultation demonstrate different ethical implications, based 
around a clinical scenario. To do this, we have applied the ethical principles of autonomy, utility and 
justice to these models. We show that the different models of consultation place varying degrees of 
emphasis on risk communication, patient autonomy and biomedical utility. This has implications for 
the way care is delivered both for the individual patient and for the population as a whole. 
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Introduction 
Risk is defined as the probability that a hazard will give rise to harm. Risk communication is a two-
way discussion about risk that enables a better understanding of the risk in question. The goals of 
risk communication are to share information, change beliefs and behaviour where relevant and 
enable patients to make informed decisions based on understanding the risks. 
Risk communication is commonly used in clinical practice. There is a substantial evidence base 
describing the competencies required to perform it effectively.1 Examples of risk communication 
include a discussion of cardiovascular risk before commencing a statin for primary prevention of 
cardiovascular disease, or a discussion of breast cancer risk in an asymptomatic patient who is 
considering screening.  
The National Institute for Health and Care Excellence (NICE) emphasizes that clinicians should take 
iŶto aĐĐouŶt patieŶts͛ Ŷeeds, values, opinions and preferences, and that patients should be enabled 
to make informed decisions regarding their care. There is promising evidence to show that effective 
risk communication facilitates individualized goal-setting, shared decision-making and improved 
adherence to treatment. Different clinicians employ different consultation styles with their patients. 
These different styles incorporate risk communication in different ways and place differing levels of 
importance on it. 
Communication of risk involves ethical choice. If patients are given all the relevant information and 
encouraged to make decisions based on this, will this always be helpful or could this be detrimental 
to soŵeoŶe͛s health in comparison with the clinician making the decision alone? Might the 
responsibility of the decision-making worry the patient? What implications does informed decision-
making have on healthcare costs and public health?  
Here, we discuss the varying degrees to which risk communication is used in different consultation 
approaches and analyse their ethical implications. 
 
An illustrative case 
As stated, risk messages are common in clinical practice. Table 1 outlines a clinical scenario in which 
risk communication might be employed. 
 
Different consultation approaches and risk communication 
Doctors use a variety of consultation approaches, and these can vary in risk communication. In the 
paternalistic model, the doctor listens to the patieŶt͛s stoƌǇ, ŵakes a decision about the nature of 
the problem and then uses their knowledge to provide the care they believe is iŶ the patieŶt͛s ďest 
interests. Risk communication may be omitted if it is thought to be in the patieŶt͛s best interests.  
With the shared-decision making (SDM) model, the doctor again listens to the patient͛s story but 
then involves the patient in decision-making to the extent desired by the patient. Risk 
communication is integral to the SDM model, particularly at the stage at which options are described 
and the harms and benefits associated with each option discussed.2 At least some information must 
be both provided and discussed to enable the patient to be involved in the decision-making process.  
For the purposes of this article, we discuss the ethical implications of using the paternalistic model 
versus the SDM model when dealing with Mr Davies, described in Table 1. 
 
Paternalistic approach 
From looking at Mƌ Daǀies͛ Q‘ISKϮ sĐoƌe,3 the general practitioner (GP) is likely to discuss 
information on dietary and lifestyle changes and then conclude that starting a statin for primary 
prevention is recommended. The GP explains that NICE guidance suggests that Mr Davies should be 
started on a statin because of his QRISK2 score. This information is used to justify the GP's decision. 
The GP does not discuss the extent to which a statin would reduce Mr Daǀies͛ ĐaƌdioǀasĐulaƌ risk but 
does counsel him about the common adverse effects of statins and suggests that he returns if he 
experiences any of these.  
We can consider the ethical implications of risk communication in the paternalistic approach using 
the three ethical principles of autonomy, utility and justice, as defined in Table 2. The paternalistic 
approach can easily emphasize biomedical utility over the patient's autonomous choice of best 
interests. The ĐliŶiĐiaŶ͛s aim should be to consider the patieŶt͛s situatioŶ in the light of their 
professional knowledge and come to a decision that they perceive would maximize utility. Risk 
communication might be omitted if this were thought to be in the patient's best interests.  
There are, however, ethical pitfalls with the paternalistic approach. First, the patieŶt͛s autoŶoŵǇ is 
ignored as they have not been involved in the decision-making process. As the patient͛s preferences 
or values have not been taken to account, this approach reduces their personal utility. It risks wrong 
judgements about what the patient would value, prefer and perceive to be beneficial and applicable 
in their personal situation. The paternalistic approach is not usually justifiable because the patieŶt͛s 
goals and values are not taken into account and the patient is not involved in the decision-making 
process. Nevertheless, it remains a common model in clinical practice. 
 
Shared decision-making approach 
The GP seeks to involve Mr Davies in the decision-making process, and Mr Davies appears 
comfortable with participating in the process. The SDM model is based on ͚optional autonomy͛ as 
the patient determines the extent of their involvement in the decision-making process. The GP lists 
the options for treatment, iŶĐludiŶg ͚Ŷo aĐtioŶ͛, eǆplaiŶs the pƌos aŶd ĐoŶs of eaĐh optioŶ aŶd 
explores the patient͛s expectations and concerns. In the SDM model, risk communication is 
͚enforced͛, although the degree to which it features varies.  
Table 3 highlights ways that we could improve risk communication in practice. To help Mr Davies to 
make a decision, the GP gives him the absolute risk reduction (ARR) from statin use in the primary 
prevention of cardiovascular disease, as well as Mƌ Daǀies͛ personalized QRISK2 score. Most patients 
wish to know the numerical benefit of a preventive drug, and Mr Davies is grateful for this 
information. The GP ĐheĐks Mƌ Daǀies͛ uŶdeƌstaŶdiŶg of the iŶfoƌŵatioŶ giǀeŶ. Mƌ Daǀies 
understands the information and decides to improve his diet, reduce his alcohol intake and stop 
smoking. He decides against a statin following discussion of the ARR in cardiovascular disease. He is 
not impressed by the reported benefits and is worried about the potential adverse effects 
discussed.4 
From an ethical perspective, the improved autonomy of the SDM approach may be beneficial for 
patients willing to participate in decision-making but undesirable for those who want their doctor to 
make the decision. Enforced risk communication can unduly harm patients and may not therefore 
maximize overall benefit. The patieŶt͛s decision may contradict current recommendations and 
practice, which can reduce biomedical utility, particularly at the level of population health. For 
example, uptake of statins is low following individualized risk communication based on the benefits 
presented in terms of ARR or prolongation of life.4 This is consistent with the known tensions found 
between public health, guidelines and informed decision-making.5 Finally, if the doctor prioritizes 
the patieŶt͛s right to share decisions, limited healthcare resources may be distributed on the basis of 
the patieŶts͛ skills iŶ shaƌiŶg deĐisioŶs ƌatheƌ thaŶ oŶ ŵediĐal aŶd soĐial Ŷeed. Alternatively, the GP 
may be aware of the rights of patients who are less capable of sharing decisions and will not allow 
shared decisions to dictate resource use without constraint. 
 
  
Table 1 Mr Davies͛ situatioŶ 
Mr Davies has just celebrated his 54th birthday. He is currently feeling well but wanted to have a 
check-up by his GP as his father died of a heart attack when he was 49. Mr Davies smokes 30 
cigarettes a day. He drinks around 50 units of alcohol a week and takes very little exercise. He 
works at a local supermarket. 
Examination reveals a body mass index of 34.7 kg/m2 and blood pressure of 136/83 mmHg. Blood 
tests record a total cholesterol level of 5.8 mmol/litre with an high-density lipoprotein cholesterol 
of 1.3 mmol/litre. The glycated haemoglobin concentration is 39 mmol/litre. 
Mƌ Daǀies͛ QRISK2 score is 23% over 10 years. 
 Table 2Definitions of ethical principles 
les  
 
 Definition 
Autonomy Deliberated self-rule. If a person has autonomy, 
they can make their own decisions on the basis 
of deliberation 
Utility The condition where benefit is maximized and 
harm minimized 
Justice The moral obligation to act on the basis of fair 
adjudication between competing claims. For 
justice to be fair, it is important to treat equals 
equally and to treat unequals unequally in 
proportion to the relevant inequalities 
Table 3  Methods used to communicate risk 
 
Risk representations  
Absolute risk reduction (ARR) is a more balanced and understandable representation of risk 
reduction for patients and clinicians than relative risk reduction (RRR) and number-needed-to-treat 
(NNT). The following example describes the communication of risks related to a screening test where 
identical benefits are described in terms of ARR, RRR and NNT: 
 ARR: If you have this test every 2 years, it will reduce your chance of dying from this cancer 
from around 4 in 1000 to 3 in 1000 over the next 10 years  RRR: If you have this test every 2 years, it will reduce your chance of dying from this cancer 
by around one-quarter over the next 10 years  NNT: If around 1000 people had this test every 2 years, 1 person would be saved from dying 
from cancer every 10 years. 
Personalizing risk information 
Risk is expressed as a numerical estimate or category based on personal risk factors, for example 
QRISK2 for cardiovascular events. These can often be seen as more relevant by the patient. The use 
of risk personalization tools such as the Breast Cancer Risk Assessment Tool 
(http://www.cancer.gov/bcrisktool/) has been shown to enhance informed choice and participation 
in screening. 
Decision aids 
These help to iŵpƌoǀe the patieŶt͛s kŶoǁledge, aĐĐuƌate ƌisk peƌĐeptioŶ aŶd paƌtiĐipatioŶ iŶ 
decision-making. They can also support shared decision-making between clinicians and patients. 
Option grids (optiongrid.org) are a set of decision aids that help patients and clinicians choose 
between alternative treatments options in a variety of conditions. 
Framing 
͚FƌaŵiŶg ŵaŶipulatioŶ͛ is the pƌeseŶtatioŶ of eƋuiǀaleŶt data iŶ diffeƌeŶt ǁaǇs. Attƌiďute fƌaŵiŶg is 
the positive versus negative description of a specific attribute of a single item or state. For example, 
a patient recently diagnosed with colorectal cancer could be told that there is a 60% chance that 
they will survive for 5 years (positive framing) or a 40% chance that they will die within 5 years of the 
diagnosis (negative framing). Work has shown that interventions are seen as more beneficial by 
patients when presented using positive framing. 
Goal framing, presented as a gain versus a loss, describes the consequences of performing or not 
peƌfoƌŵiŶg aŶ aĐt. Foƌ eǆaŵple ͚takiŶg a statin would increase your chance of not having a heart 
attaĐk͛ ǀeƌsus ͚Ŷot takiŶg a statiŶ ǁould iŶĐƌease Ǉouƌ ĐhaŶĐe of haǀiŶg a heaƌt attaĐk͛. Loss 
messages are seen to be most effective. 
Natural frequencies 
With natural frequencies, numerical values are expressed as event rates in groups with or without 
the ĐoŶsideƌed iŶteƌǀeŶtioŶ. Foƌ eǆaŵple ͚aŵoŶg ϭϬϬ people ǁho take a statiŶ, 9ϱ people ǁill Ŷot 
get heaƌt disease. AŵoŶg ϭϬϬ people ǁho do Ŷot take a statiŶ, 9ϯ people ǁill Ŷot get heaƌt disease͛. 
It is thought that the use of natural frequencies, compared with probabilities and percentages, 
improves understanding of risk. 
  
Key points  Risk communication is an important part of clinical practice  Different communication approaches place differing emphasis on risk communication and 
bring up different ethical issues  The traditional paternalistic model emphasizes utility over autonomy, and risk 
communication can be omitted if it is not perceived to be in the best interests of the patient  Shared decision-making plaĐes the eŵphasis oŶ ͚optioŶal͛ autoŶoŵǇ, and risk 
communication is an integral requirement for this. Some feel that this approach can reduce 
utility with regard to the individual patient and the population as a whole 
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Test yourself  
To test your knowledge based on the article you have just read, please complete the questions 
below . 
 
Question 1. A 50-year-old woman with no previous medical history presented to her GP to discuss 
mammorgraphy screening. She had no family history of cancer, had had  her first period aged 13 and 
had delivered her first child when she was age 23. She wished to know more about mammography 
screening before making a final decision. A variety of consultation approaches could have been used 
for this consultation, each with different ethical stands and goals.  
Which of the consultation approaches below is most in keeping with the shared decision-making 
approach? 
 
A. The GP uses their knowledge of mammography to make a decision on whether they think 
mammography is in the patieŶt͛s best interest. The GP gives little information about the 
benefits and harms of mammography screening. The ethical emphasis is on utility and 
justice over autonomy 
B. The GP provides information on the harms and benefits of mammography screening. They 
involve the patient in decision-making to the extent she desires. Theƌe is ͚optioŶal͛ 
autonomy but mandatory information provision 
C. The GP gives information on the harms and benefits of mammography screening. They then 
leave it up to the patient to make the final decision. The ethical emphasis is on autonomy, 
with the patient having to make the final decision 
D. The GP allows the patient to direct the consultation regarding mammography screening, 
listening to her views and concerns. The GP does not give their views on mammography 
sĐƌeeŶiŶg ďut ƌatheƌ aĐts as a listeŶeƌ, faĐilitatiŶg the patieŶt͛s stoƌǇ aŶd alloǁiŶg the patieŶt 
to ŵake heƌ deĐisioŶ. The ethiĐal eŵphasis is oŶ autoŶoŵǇ aŶd ƌespeĐtiŶg the patieŶt͛s ƌight 
to set the agenda 
E. The GP allows the patient to direct the consultation regarding mammography screening, 
listening to her views and concerns. The patient asks the GP about the benefits and risks of 
mammography and they discuss this, allowing the patient to reflect on how compatible they 
aƌe ǁith heƌ situatioŶ. The GP pƌiŵaƌilǇ aĐts as a listeŶeƌ, faĐilitatiŶg the patieŶt͛s stoƌǇ aŶd 
allowing the patient to make a decision herself. The ethical emphasis is on autonomy and 
ƌespeĐtiŶg the patieŶt͛s ƌight to set the ageŶda 
 
 
Answer: B. 
Feedback: A represents a paternalistic approach, with the GP making a decision based on what they 
perceives to ďe the patieŶt͛s ďest iŶteƌests. B ƌepƌeseŶts a shaƌed decision-making approach, and 
the patient is involved in decision-making to the extent she desires. C represents an infomed choice 
approach; there is mandatory information provision but the patient is made to make the final 
decision. D and E represent a narrative consultation approach in which the GP listeŶs to the patieŶt͛s 
story and facilitates further discussion. 
 
 
Question 2. A 60-year-old gentleman with known ischaemic heart disease presented to his GP to 
discuss bowel cancer cancer screening. His father had died from stomach cancer aged 64. The 
patient wished to know more about bowel screening before making a final decision on whether to 
take part. His GP informed him that if he had bowel screening every 2 years, it would reduce his 
chance of dying from bowel cancer from around 28 in 100,000 to 23 in 100,000 over the next 10 
years.  
What is the absolute risk reduction of mortality from bowel cancer from bowel cancer screening? 
 A. 0.82 
B. 20,000 
C. 5 in 100,000 
D. 5 in 1000 
E. 0.6 
 
Answer: C. 
Feedback: Answer A represents the relative risk, which is calculated by the absolute risk in the 
treatment group (ART) divided by the absolute risk in the control group (ARC). B represents the 
number-needed-to-treat, which is calculated by: 1/absolute risk reduction. C represents the absolute 
risk reduction, which is calculated by: ARC – ART. D and E are both wrong. 
 
 
Question 3. A 59-year-old gentleman with a history of rheumatoid arthritis presented to his GP as his 
rheumatologist had advised him to see the GP regarding his cardiovascular risk status. The patient 
had been meaning to do this as his father had died at the age of 58 from a myocardial infarction. The 
patient has no cardiovascular history and has never smoked. Examination revealed a body mass 
index of 24 kg/m2 and blood pressure of 148/92 mmHg. Blood tests showed a total cholesterol/HDL 
ƌatio of ϰ.ϱ. The patieŶt͛s Q‘ISKϮ sĐoƌe was 21.4% over 10 years. The GP recommended that the 
patient should start atorvastatin 20 mg daily. Before doing this, the patient wanted to know how 
effective atorvastatin would be in reducing his risk of having a cardiovascular event.  
Which of the following representations of risk reduction should be used by the GP? 
A. Relative risk reduction 
B. Number-needed-to-treat 
C. Absolute risk reduction 
D. Odds ratio 
E. Prolongation of life 
Answer: C. 
Feedback: Answer A makes treatment benefits and changes in risk seem larger than they actually 
are. B tends to be less well understood by patients and clinicians than relative risk reduction and 
absolute risk reduction. C is seen to be a more accurate representation of risk than relative risk 
reduction and is better understood than the number-needed-to-treat. D is commonly interpreted 
wrongly by patients and doctors. When risk is communicated using E, it usually results in a much 
lower proportion of people choosing therapy compared with other representations of risk reduction 
such as absolute risk reduction. Although it can be argued that this reduction of uptake represents 
informed choice, it is at odds with the public health strategy to reduce cardiovascular risk. 
 
